Glaucoma Surgery Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Summary
GlobalData's Medical Devices sector report, “Glaucoma Surgery Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Glaucoma Surgery Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Glaucoma surgery devices are used to augment normal physiologic aqueous outflow pathways in order to provide effective intra-ocular pressure.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Glaucoma Surgery Devices under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Glaucoma Surgery Devices and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Glaucoma Surgery Devices under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
Introduction
Glaucoma Surgery Devices Overview
Products under Development
Glaucoma Surgery Devices - Pipeline Products by Stage of Development
Table Figure 1: Glaucoma Surgery Devices - Pipeline Products by Stage of Development
Table Glaucoma Surgery Devices - Pipeline Products by Stage of Development
Glaucoma Surgery Devices - Pipeline Products by Segment
Table Figure 2: Glaucoma Surgery Devices - Pipeline Products by Segment
Table Glaucoma Surgery Devices - Pipeline Products by Segment
Glaucoma Surgery Devices - Pipeline Products by Territory
Table Figure 3: Glaucoma Surgery Devices - Pipeline Products by Territory
Table Glaucoma Surgery Devices - Pipeline Products by Territory
Glaucoma Surgery Devices - Pipeline Products by Regulatory Path
Table Figure 4: Glaucoma Surgery Devices - Pipeline Products by Regulatory Path
Table Glaucoma Surgery Devices - Pipeline Products by Regulatory Path
Glaucoma Surgery Devices - Pipeline Products by Estimated Approval Date
Table Figure 5: Glaucoma Surgery Devices - Pipeline Products by Estimated Approval Date
Table Glaucoma Surgery Devices - Pipeline Products by Estimated Approval Date
Glaucoma Surgery Devices - Ongoing Clinical Trials
Table Figure 6: Glaucoma Surgery Devices - Ongoing Clinical Trials
Table Glaucoma Surgery Devices - Ongoing Clinical Trials
Glaucoma Surgery Devices - Pipeline Products under Development by Companies
Glaucoma Surgery Devices Companies - Pipeline Products by Stage of Development
Table Glaucoma Surgery Devices Companies - Pipeline Products by Stage of Development
Glaucoma Surgery Devices - Companies Pipeline Products by Stage of Development
Table Glaucoma Surgery Devices - Companies Pipeline Products by Stage of Development
Glaucoma Surgery Devices Companies and Product Overview
Table Ciliatech Therapeutics AG - Ongoing Clinical Trials Overview
Table Cilio-Scleral Inter-Positioning Device - Monocentre, Observational Clinical Study Evaluating the Efficacy and Safety of a Novel Interposition Supraciliary Implant in Glaucoma Surgery
Table Cilio-Scleral Inter-Positioning Device - Multicentre, Non-randomised Clinical Study Evaluating the Efficacy and Safety of Cilioscleral Interposition Device v2.2 in Glaucoma Surgery
Table Cilio-Scleral Inter-Positioning Device - Non Randomised Mono-centered Study to Evaluate Safety and Efficacy of a Novel Cilioscleral Interposition Device (CID) SV22 in Glaucoma Patients Refractory to Topical Therapy
Table Cilio-Scleral Inter-Positioning Device - Non Randomized Mono-centered Study to Evaluate Safety and Efficacy of a Novel Interposition Supraciliary Implant in Glaucoma Patients Refractory to Topical Therapy
Geuder AG Pipeline Products & Ongoing Clinical Trials Overview
Table Geuder AG Pipeline Products & Ongoing Clinical Trials Overview
Table Microsystem Implant - Product Status
Table Microsystem Implant - Product Description
Glaucot Teknoloji AS Company Overview
Glaucot Teknoloji AS Pipeline Products & Ongoing Clinical Trials Overview
Table Glaucot Teknoloji AS Pipeline Products & Ongoing Clinical Trials Overview
Table GlaucoT - Product Status
Table GlaucoT - Product Description
Table Glaucot Teknoloji AS - Ongoing Clinical Trials Overview
Table GlaucoT - Pilot Study to Evaluate Clinically the Short-Term Efficacy of GlaucoT Glaucoma Treatment Glasses in the Treatment of Primary Open-Angle Glaucoma (GlaucoT)
Table CycloPen Cyclodialysis System - An Observational Registry Study of Safety and Effectiveness Outcomes Through 24 Months Postoperatively Following CycloPen Micro-Interventional Cyclodialysis System Procedures in Patients With Open Angle Glaucoma
iSTAR Medical SA Pipeline Products & Ongoing Clinical Trials Overview
Table iSTAR Medical SA Pipeline Products & Ongoing Clinical Trials Overview
Table MINIject - Product Status
Table MINIject - Product Description
Table STARflo MINI - Product Status
Table STARflo MINI - Product Description
Table STARflo Plus Glaucoma Implant - Product Status
Table STARflo Plus Glaucoma Implant - Product Description
Table iSTAR Medical SA - Ongoing Clinical Trials Overview
Table MINIject - A Prospective, Multicenter Masked Clinical Trial to Evaluate the Safety and Effectiveness of the MINIject CS627 Implant in Subjects with Open Angle Glaucoma
Table MINIject - A Prospective, Open, Clinical Trial Analysing the Efficacy and Safety of Miniject (MINI SO627) in Patients With Open Angle Glaucoma Uncontrolled by Topical Hypotensive Medications Using a Single Operator Delivery Tool
Table MINIject - A Prospective, Open, Multicenter Clinical Trial Evaluating the Efficacy and Safety of MINIject Combined with Cataract Surgery in Patients with POAG Uncontrolled by Topical Hypotensive Medications and Operable Age-related
Table MINIject - A Prospective, Open, Multicenter Study Analysing the Long-term Safety of MINIject Glaucoma Implants in Patients with Open Angle Glaucoma Uncontrolled by Topical Hypotensive Medications
Table MINIject - STAR-LIFE: A Post-market Registry on MINIject
Table Pneumatic Trabeculoplasty System - Product Status
Table Pneumatic Trabeculoplasty System - Product Description
Glaucoma Surgery Devices- Recent Developments
Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair
Aug 15, 2023: Alcon Reports Second Quarter 2023 Results
Jul 12, 2023: Ocular Therapeutix Announces Appointment of New Board Member
May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023
May 08, 2023: Ocular Therapeutix provides first quarter 2023 financial results and corporate update
Apr 25, 2023: OPKO Health to report Q1 2023 financial results on May 3, 2023
Apr 12, 2023: Medtronic has a layoff in California
Mar 29, 2023: STAAR Surgical Names Warren Foust Chief Operating Officer; Magda Michna, Ph.D., Chief Clinical, Regulatory and Medical Affairs Officer
Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company
Feb 21, 2023: Ocular Therapeutix To Report Fourth Quarter and Year-End 2022 Financial Results
Feb 16, 2023: OPKO Health to Report Fourth Quarter 2022 Financial Results on February 23, 2023
Feb 01, 2023: Glaukos to Release Fourth Quarter and Full Year 2022 Financial Results after Market Close on February 22
Jan 09, 2023: STAAR Surgical Reports Preliminary Sales for Fourth Quarter and Fiscal 2022
Jan 09, 2023: New high-tech startup developing smart contact lenses for glaucoma diagnosis and management
Jan 04, 2023: Verana Health and Sight Sciences collaborate on glaucoma research using curated realworld data from the IRIS registry
Dec 21, 2022: Wilmington Eye ophthalmic surgeon implants first-ever glaucoma device in the Carolinas
Nov 23, 2022: Medtronic Reports Quarterly Earnings
Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results
Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday
Nov 15, 2022: ViaLase Strengthens Executive Team with the Appointments of Tom Frinzi as Executive Chairman of the Board Richard Lewis M.D. as Chief Medical Officer and Shawn O'Neil as Chief Commercial Officer
Nov 08, 2022: Zhaoke Ophthalmology : Reaching exclusive distribution agreement to commercialize TONO-i in greater China for self-measurement of intraocular pressure
Oct 24, 2022: Ocular Therapeutix To Report Third Quarter 2022 Financial Results
Sep 28, 2022: Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2022 American Academy of Ophthalmology Annual Meeting
Sep 22, 2022: Ocular Therapeutix To Present Data at the American Academy of Ophthalmology 2022 Annual Meeting